Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $143,008 | 76 | 86.1% |
| Food and Beverage | $10,104 | 463 | 6.1% |
| Travel and Lodging | $8,981 | 73 | 5.4% |
| Consulting Fee | $3,819 | 4 | 2.3% |
| Education | $153.03 | 12 | 0.1% |
| Gift | $18.00 | 1 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Janssen Pharmaceuticals, Inc | $64,896 | 113 | $0 (2020) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $39,529 | 77 | $0 (2023) |
| AstraZeneca Pharmaceuticals LP | $34,796 | 60 | $0 (2020) |
| ABBVIE INC. | $17,787 | 39 | $0 (2024) |
| Lilly USA, LLC | $4,403 | 45 | $0 (2024) |
| Novo Nordisk Inc | $910.02 | 55 | $0 (2024) |
| Amgen Inc. | $693.23 | 40 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $524.19 | 36 | $0 (2023) |
| Shire North American Group Inc | $189.40 | 8 | $0 (2019) |
| Abbott Laboratories | $183.11 | 9 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $742.75 | 38 | Novo Nordisk Inc ($197.77) |
| 2023 | $573.32 | 31 | Novo Nordisk Inc ($99.21) |
| 2022 | $556.45 | 34 | Amgen Inc. ($79.90) |
| 2021 | $512.90 | 31 | Novo Nordisk Inc ($171.50) |
| 2020 | $6,685 | 21 | Janssen Pharmaceuticals, Inc ($5,355) |
| 2019 | $20,739 | 107 | Janssen Pharmaceuticals, Inc ($9,639) |
| 2018 | $44,348 | 186 | Boehringer Ingelheim Pharmaceuticals, Inc. ($14,988) |
| 2017 | $91,926 | 181 | Janssen Pharmaceuticals, Inc ($42,543) |
All Payment Transactions
629 individual payment records from CMS Open Payments — Page 1 of 26
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $16.29 | General |
| Category: Obesity | ||||||
| 12/17/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $26.27 | General |
| 12/16/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $25.87 | General |
| Category: Inflammation | ||||||
| 12/11/2024 | Bausch Health US, LLC | APLENZIN (Drug) | Food and Beverage | In-kind items and services | $15.03 | General |
| Category: Neurology | ||||||
| 12/09/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $22.83 | General |
| Category: Cardio-renal | ||||||
| 12/03/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $12.56 | General |
| 11/20/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $20.09 | General |
| Category: Inflammation/Rare Disease | ||||||
| 11/12/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $14.04 | General |
| Category: Hyperthyroidism | ||||||
| 11/11/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $23.43 | General |
| Category: Cardio-renal | ||||||
| 11/07/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.34 | General |
| 11/06/2024 | Insulet Corporation | Omnipod (Device) | Food and Beverage | Cash or cash equivalent | $24.58 | General |
| Category: Insulin Pump | ||||||
| 10/23/2024 | Currax Pharmaceuticals LLC | CONTRAVE (Drug) | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Obesity | ||||||
| 10/17/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $20.27 | General |
| Category: Obesity | ||||||
| 09/26/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $18.76 | General |
| 09/17/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Bone Health | ||||||
| 09/04/2024 | Tolmar, Inc. | JATENZO (Drug) | Food and Beverage | Cash or cash equivalent | $14.37 | General |
| Category: HORMONE REPLACEMENT | ||||||
| 08/28/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $21.17 | General |
| 08/01/2024 | Acella Pharmaceuticals, LLC | NP Thyroid 60 (Drug) | Food and Beverage | In-kind items and services | $24.84 | General |
| Category: Hyperthyroidism | ||||||
| 07/16/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $22.92 | General |
| Category: Diabetes | ||||||
| 05/23/2024 | ABBVIE INC. | UBRELVY (Drug), SYNTHROID | Food and Beverage | In-kind items and services | $24.15 | General |
| Category: NEUROSCIENCE | ||||||
| 05/15/2024 | Currax Pharmaceuticals LLC | ONZETRA XSAIL (Drug), CONTRAVE | Food and Beverage | In-kind items and services | $13.48 | General |
| Category: Neurology | ||||||
| 05/14/2024 | Tandem Diabetes Care, Inc. | t:slim X2 Insulin Pump with Control-IQ (Device) | Food and Beverage | In-kind items and services | $30.14 | General |
| Category: Endocrinology | ||||||
| 05/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.20 | General |
| Category: Diabetes | ||||||
| 05/02/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $19.81 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 04/18/2024 | MILLICENT US INC | FEMRING (Drug), INTRAROSA | Food and Beverage | In-kind items and services | $18.94 | General |
| Category: TREAT SYMPTOMS OF MENOPAUSE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 504 | 882 | $186,950 | $76,534 |
| 2022 | 3 | 496 | 901 | $191,390 | $79,471 |
| 2021 | 3 | 429 | 859 | $182,050 | $76,721 |
| 2020 | 3 | 424 | 900 | $191,440 | $70,726 |
All Medicare Procedures & Services
12 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 313 | 682 | $135,950 | $58,064 | 42.7% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2023 | 129 | 138 | $32,640 | $11,104 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $18,360 | $7,367 | 40.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 303 | 702 | $139,950 | $60,811 | 43.5% |
| 76536 | Ultrasound scan of head and neck soft tissue | Office | 2022 | 127 | 133 | $31,800 | $10,813 | 34.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 66 | 66 | $19,640 | $7,847 | 40.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 268 | 676 | $134,950 | $59,795 | 44.3% |
| 76536 | Ultrasound of head and neck | Office | 2021 | 108 | 130 | $31,200 | $11,039 | 35.4% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 53 | 53 | $15,900 | $5,887 | 37.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 251 | 697 | $138,500 | $51,965 | 37.5% |
| 76536 | Ultrasound of head and neck | Office | 2020 | 98 | 128 | $30,600 | $10,106 | 33.0% |
| 99204 | New patient office or other outpatient visit, typically 45 minutes | Office | 2020 | 75 | 75 | $22,340 | $8,655 | 38.7% |
About Dr. Chhay Tay, MD
Dr. Chhay Tay, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Humble, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962460741.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Chhay Tay, MD has received a total of $166,082 in payments from pharmaceutical and medical device companies, with $742.75 received in 2024. These payments were reported across 629 transactions from 48 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($143,008).
As a Medicare-enrolled provider, Tay has provided services to 1,853 Medicare beneficiaries, totaling 3,542 services with total Medicare billing of $303,452. Data is available for 4 years (2020–2023), covering 12 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location Humble, TX
- Active Since 05/02/2006
- Last Updated 07/15/2010
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1962460741
Products in Payments
- INVOKANA (Drug) $64,772
- JARDIANCE (Drug) $43,391
- FARXIGA (Drug) $24,545
- BYDUREON (Drug) $10,250
- Synthroid (Drug) $10,232
- Androgel (Drug) $7,434
- TRULICITY (Drug) $346.47
- EVENITY (Biological) $272.76
- Saxenda (Drug) $264.89
- TOUJEO (Drug) $185.73
- SOLIQUA (Drug) $174.95
- Prolia (Biological) $169.10
- Dexcom G6 Transmitter (Medical Supply) $157.55
- Ozempic (Drug) $155.58
- CONTRAVE (Drug) $150.91
- Livalo (Drug) $137.71
- Aimovig (Biological) $127.88
- NATPARA (Drug) $118.85
- Strensiq (Drug) $118.79
- XARELTO (Drug) $117.13
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Humble
Dr. Brian Chou, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $23,555
Dr. Syed Shahid, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $11,825
Wilson Sze
Endocrinology, Diabetes & Metabolism — Payments: $7,204